SHCBP1 and pancreatic neoplasm: Structure-based virtual screening using the AlphaFold-predicted SHCBP1 model identified AZD5582 as a potential SHCBP1-binding compound, which can suppress pancreatic cancer growth and metastasis through induction of apoptosis [77].